Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787448 · ClinicalTrials.gov registry record · Phase 1
RIPT of Ibuprofen Topical Gel
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 234
- Enrollment target
NCT01787448 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 234 participants.
The verdict
NCT01787448, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 234 participants
- Enrollment target
Study Summary
This study is being conducted to determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause sensitization after repeated topical application to healthy skin of human subjects under controlled conditions.
Interventions
- DRUG Topical gel vehicle
- DRUG Sodium chloride solution 0.9% (saline)
- DRUG Sodium lauryl sulfate 0.1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01787448
The ClinicalTrials.gov registry entry for NCT01787448 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Topical gel vehicle is the first listed.
NCT01787448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01787448 about?
NCT01787448 is a clinical study titled "RIPT of Ibuprofen Topical Gel". This study is being conducted to determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause sensitization after repeated topical application to healthy skin of human subjects under controlled conditions.
What is the current status of trial NCT01787448?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 234 participants. The study started on 2013-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01787448?
The interventions under investigation include: Topical gel vehicle (DRUG), Sodium chloride solution 0.9% (saline) (DRUG), Sodium lauryl sulfate 0.1% (DRUG).
Who is sponsoring clinical trial NCT01787448?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.